Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Complexity-enhancing drugs to treat disorders of consciousness: ketamine study
2021-002321-23Phase 2Active
- Sponsor
- University of Liège
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ketamine in disorder of consciousness (DOC), vegetative state (VS), Minimally conscious state (MCS) and 1 more, sponsored by University of Liège. Started Feb 2022; status: active.
02
Drugs
ketamine
03
Conditions
disorder of consciousness (DOC)vegetative state (VS)Minimally conscious state (MCS)acquired brain injury (ABI)
Beyond the preview
Go deeper on 2021-002321-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002321-23.